x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:07:35

Swiss Biotech Day: Zurich based LimmaTech Biologics...

BiotechTV - News ·

2025/05/05

CEO Franz-Werner Haas describes the rationale for developing vaccines for the antimicrobial space, he explains the company's E. coli based platform, and he walks us through the pipeline.

en-us

00:08:59

Swiss Biotech Day: Basel based Nouscom presented data...

BiotechTV - News ·

2025/05/05

CEO Marina Udier describes the vaccine's design, what was presented at AACR, and discussions the company has had with U.S. FDA about running a registrational study. Plus, previewing upcoming data later this year in metastatic colorectal cancer.

en-us

00:13:21

Swiss Biotech Day: Molecular Partners' CEO and Swiss...

BiotechTV - News ·

2025/05/05

He describes the clinical multi-specific T-cell engager program that will have data this year, and highlights the idea behind a next-generation logic-gating platform. Plus, entering the clinic with a DLL3 radio-DARPin and choosing mesothelin as a second target.

en-us

00:07:55

At a reception on the eve of Swiss Biotech Day, Swiss...

BiotechTV - News ·

2025/05/04

He describes the goals of Swiss Biotech Day, explains how the Swiss biotech sector is funded more by private investment than perhaps other geographies, and discusses current events.

en-us

00:23:52

Biotech investor Thilo Schroeder of Nextech Invest...

BiotechTV - News ·

2025/05/02

He describes the history of Nextech, including being an early investor in Blueprint Medicines and Peloton, and discusses the importance of investing in companies that have a wide moat to protect from today's fierce global competition.

en-us

00:12:28

VERAXA Biotech, which is part of Switzerland's Xlife...

BiotechTV - News ·

2025/05/02

Xlife Sciences CEO Oliver Baumann introduces us to the fund, which is publicly traded in Switzerland, while VERAXA CEO Christoph Antz describes the BiTAC AND-gating platform the company uses to improve on the precision of T-cell engagers and antibody-drug conjugates.

en-us

00:14:57

Zurich based CUTISS is developing a personalized...

BiotechTV - News ·

2025/05/01

Co-Founder & CEO Daniela Marino describes why CUTISS believes denovoSKIN is superior to autografting. She describes how they make it, walks us through the company's on-site GMP facility, and she discusses the clinical experience to date. The therapy is already in a phase 3 study in Europe.

en-us

00:12:20

London based Baseimmune shows BiotechTV the new space...

BiotechTV - News ·

2025/04/29

Co-founder & CEO Joshua Blight talks about Baseimmune's platform, which was inspired by the work that happened during COVID both in the UK and abroad. The company's current focus is on COVID and malaria.

en-us

00:10:51

Creyon Bio today announced a collaboration to help...

BiotechTV - News ·

2025/04/29

Recently named CEO Serge Messerlian, who was previously CEO of Teon Therapeutics and President of Janssen Oncology, describes the platform behind this deal, which came with an upfront payment/investment of $13 million.

en-us

00:12:14

London based Laverock shows BiotechTV the new space...

BiotechTV - News ·

2025/04/29

CEO David Venables describes Laverock's platform that repurposed miRNA to reprogram cells in a highly specific way. It's own lead programs will be in oncology and regenerative medicine.

en-us

00:09:47

The London BioScience Innovation Centre (LBIC) today...

BiotechTV - News ·

2025/04/29

Dr. Rich Ferrie gives BiotechTV a preview of the new facilities and describes how it is aimed for growing companies that have already achieved a series A or B. It has started at 37% occupancy on launch day.

en-us

00:19:04

Talking chromatin regulation at Foghorn Therapeutics...

BiotechTV - News ·

2025/04/25

CEO Adrian Gottschalk describes chromatin regulation at a high level, and walks us through the Lilly partnership targeting SMARCA2, and Foghorn's independent programs targeting CBP, EP300, and ARID1B.

en-us

00:28:48

Epicrispr Biotechnologies' CEO Amber Salzman...

BiotechTV - News ·

2025/04/25

She describes why such an analysis would be beneficial in analyzing clinical benefit for this type of condition - where the patient population is heterogenous in how they are affected by the disease. Plus, a description of Epicrispr's epigenome approach to science, and her personal relationship to facioscapulohumeral muscular dystrophy.

en-us

00:17:55

Lexeo Therapeutics' CEO Nolan Townsend highlights...

BiotechTV - News ·

2025/04/23

He describes the clinical data in FA cardiomyopathy that was announced this month, and explains how the company is preparing to begin a clinical trial for accelerated approval by early 2026. Plus, how we should expect more ACM data in 2025.

en-us

00:23:32

Metsera's CEO Whit Bernard on the obesity space,...

BiotechTV - News ·

2025/04/23

He describes how Metsera, which had its IPO two months ago, is aiming to develop a differentiated GLP-1 vs currently marketed products by having a lower dose and longer half-life. We discuss all the hot button issues in the obesity space today.

en-us

00:17:24

On its 10-year anniversary, Arcus Biosciences is...

BiotechTV - News ·

2025/04/17

He describes the market potential of the company's HIF-2⍺, a target that has already been de-risked by a large pharma, why he believes being Fc silent will allow Arcus to succeed in TIGIT where others have failed, and a CD73 program that is enrolling very quickly in pancreatic cancer.

en-us

00:12:52

As federal funding for cancer research has been...

BiotechTV - News ·

2025/04/16

CSO John Connolly describes how recent new hires and a willingness to lead will expand PICI's already broad reach in cancer research circles. Plus, his take on what regulatory reforms could help U.S. competitiveness, and areas of research that excite him today.

en-us

00:10:38

Siren Biotechnology is using an online platform to...

BiotechTV - News ·

2025/04/16

Founder and CEO Nicole Paulk describes the process, which allows the public to invest as little as $100, and why she views the investors that come with it as an asset for her company.

en-us

00:16:07

Theravance Biopharma has a key pivotal trial readout...

BiotechTV - News ·

2025/04/15

CEO Rick Winningham describes the science behind ampreloxetine, and the rationale for developing it for patients with multiple system atrophy. A commercial stage company that already receives income from two therapies (YUPELRI and TRELEGY), Theravance Biopharma's future direction and focus will be determined by the outcome of this key trial.

en-us

00:17:07

Marea Therapeutics today announced acceptance of a...

BiotechTV - News ·

2025/04/15

CEO Josh Lehrer and CSO Ethan Weiss describe the biology of the target and highlight the topline data, which was first announced at #JPM25. Plus, details on a new program targeting acromegaly.

en-us

432 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter